Sangamo Therapeutics (SGMOQ) Price to Sales (2010 - 2025)

Sangamo Therapeutics has reported Price to Sales for 16 years, with the latest figure at 8.27 in Q4 2025.

• On a quarterly basis, Price to Sales fell 75.24% year-over-year to 8.27 in Q4 2025; TTM through Dec 2025 was 2.98, a 22.22% decrease from a year earlier, with the FY2025 full-year figure at 2.98, down 20.78% from the prior year.
• Price to Sales was 8.27 for Q4 2025 at Sangamo Therapeutics, down from 388.04 in the prior quarter.
• The five-year high for Price to Sales was 388.04 in Q3 2025, with the low at 1.91 in Q1 2023.
• Average Price to Sales over 5 years is 68.89, with a median of 31.87 recorded in 2022.
• The sharpest annual moves came in 2024 and 2025: Price to Sales soared 14997.58% in 2024, then tumbled 95.77% in 2025.
• Over 5 years, Price to Sales stood at 39.11 in 2021, then tumbled by 50.82% to 19.23 in 2022, then soared by 144.92% to 47.11 in 2023, then declined by 29.1% to 33.4 in 2024, then sank by 75.24% to 8.27 in 2025.
• The last three Price to Sales figures came in at 8.27 (Q4 2025), 388.04 (Q3 2025), and 8.9 (Q2 2025), per Business Quant data.